IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,734 | -86.4% | 381 | -79.0% | 0.00% | -100.0% |
| Q2 2023 | $12,771 | +24.1% | 1,814 | +7.7% | 0.00% | 0.0% |
| Q1 2023 | $10,290 | -4.4% | 1,684 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $10,761 | +976.1% | 1,684 | +1175.8% | 0.00% | – |
| Q3 2022 | $1,000 | -66.7% | 132 | -49.0% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 259 | -7.8% | 0.00% | – |
| Q1 2022 | $4,000 | -78.9% | 281 | -72.4% | 0.00% | -100.0% |
| Q4 2021 | $19,000 | 0.0% | 1,017 | +31.6% | 0.00% | -33.3% |
| Q3 2021 | $19,000 | +216.7% | 773 | +239.0% | 0.00% | +200.0% |
| Q2 2021 | $6,000 | +200.0% | 228 | +240.3% | 0.00% | – |
| Q1 2021 | $2,000 | -33.3% | 67 | +3.1% | 0.00% | -100.0% |
| Q4 2020 | $3,000 | +200.0% | 65 | +91.2% | 0.00% | – |
| Q3 2020 | $1,000 | -75.0% | 34 | -77.3% | 0.00% | -100.0% |
| Q1 2020 | $4,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |